Cystitis with an eGFR of 38. The IDSA and ESCMID guideline defines uncomplicated cystitis in premenopausal, non-pregnant women without known urological abnormalities, and recommends first-line agents including nitrofurantoin, trimethoprim-sulfamethoxazole where resistance is low, fosfomycin and pivmecillinam [4]; short courses are appropriate [5]. The eGFR matters because renal thresholds for nitrofurantoin differ between the US label, national formularies and prescribing criteria for older adults, and 38 falls in the range where they disagree. A good answer says which source it applied and defers to local guidance.
Apixaban in life-threatening bleeding. The choice depends on the site and severity of bleeding, the time of the last dose, renal function and what the hospital stocks. Reversal strategies are shaped by the pharmacology of the anticoagulant and antidote, regulatory indications, the quality of evidence and availability [6], and guidance from the ISTH and the European Society of Anaesthesiology and Intensive Care addresses the options [7, 8]. In a randomised trial in factor Xa inhibitor-associated intracerebral haemorrhage, andexanet improved haemostatic efficacy compared with usual care but was associated with more thrombotic events [9].
Chronic hyponatraemia of 112 mmol/L. The European guideline limits the rise in sodium during the first 24 hours, and the US and European guidance differ in detail [10, 11]. The answer depends on whether the patient has severe symptoms, how long the hyponatraemia has been present, and whether there are risk factors for osmotic demyelination such as alcohol use, malnutrition, hypokalaemia or liver disease. A question that states them can be answered precisely; one that does not gets a range.